MEDANTA
Global Health Limited (MEDANTA) Stock Analysis
Global Health Limited operates Medanta, a multi-specialty hospital chain in India offering tertiary care in cardiology, oncology, and organ transplants. It serves domestic and international patients at large hospital campuses. Growth is driven by clinical reputation and bed capacity expansion. It is listed on Indian stock exchanges.
Healthcare › Medical Care Facilities
₹1,240.00
-5.54% 1W | -6.70% 52W
Market Cap
33.3k CR
P/E Ratio
60
52W High
₹1544
52W Low
₹956
Div. Yield
0.04%
Beta
0.2
50 DMA
₹1417.2
200 DMA
₹1239.6
Profit Margin
11.9%
Inst. Own.
23.3%
⚠️ BREAKDOWN
⚠️ BREAKDOWN
Fundamentals
Profit & Loss
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 780 | 844 | 836 | 809 | 861 | 957 | 943 | 931 | 1,031 | 1,099 | 1,121 | 1,159 | 1,304 |
| Expenses | 595 | 631 | 620 | 629 | 675 | 728 | 706 | 707 | 784 | 868 | 904 | 915 | 1,017 |
| Operating Profit | 184 | 213 | 216 | 179 | 186 | 228 | 238 | 225 | 247 | 231 | 217 | 244 | 287 |
| OPM % | 24% | 25% | 26% | 22% | 22% | 24% | 25% | 24% | 24% | 21% | 19% | 21% | 22% |
| Other Income | 15 | 21 | 18 | 27 | 22 | 18 | 16 | -27 | 20 | 36 | -15 | 37 | 22 |
| Interest | 18 | 20 | 18 | 18 | 18 | 16 | 16 | 15 | 14 | 17 | 22 | 27 | 27 |
| Depreciation | 40 | 43 | 44 | 45 | 47 | 49 | 48 | 49 | 45 | 50 | 61 | 67 | 69 |
| Profit before tax | 141 | 171 | 172 | 143 | 144 | 181 | 189 | 133 | 208 | 200 | 120 | 187 | 213 |
| Tax % | 28% | 27% | 28% | 11% | 26% | 28% | 24% | 24% | 24% | 21% | 21% | 24% | 26% |
| Net Profit | 102 | 125 | 124 | 127 | 106 | 131 | 143 | 101 | 159 | 158 | 95 | 142 | 157 |
| EPS in Rs | 3.80 | 4.66 | 4.61 | 4.74 | 3.96 | 4.87 | 5.32 | 3.78 | 5.92 | 5.89 | 3.54 | 5.36 | 5.90 |
| Metric | Mar 2016 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,382 | 1,343 | 1,456 | 1,500 | 1,447 | 2,167 | 2,710 | 3,275 | 3,692 | 4,410 | 4,683 |
| Expenses | 1,081 | 1,218 | 1,283 | 1,309 | 1,250 | 1,709 | 2,073 | 2,466 | 2,806 | 3,480 | 3,705 |
| Operating Profit | 301 | 125 | 172 | 192 | 197 | 458 | 637 | 809 | 886 | 930 | 979 |
| OPM % | 22% | 9% | 12% | 13% | 14% | 21% | 24% | 25% | 24% | 21% | 21% |
| Other Income | 45 | 49 | 50 | 44 | 31 | 39 | 49 | 75 | 29 | 98 | 80 |
| Interest | 14 | 28 | 38 | 57 | 73 | 86 | 86 | 84 | 74 | 90 | 92 |
| Depreciation | 70 | 86 | 102 | 115 | 123 | 130 | 150 | 173 | 194 | 223 | 246 |
| Profit before tax | 262 | 60 | 83 | 64 | 32 | 281 | 449 | 627 | 647 | 715 | 720 |
| Tax % | 35% | 45% | 38% | 43% | 11% | 30% | 27% | 24% | 26% | 23% | |
| Net Profit | 170 | 33 | 51 | 36 | 29 | 196 | 326 | 478 | 481 | 554 | 552 |
| EPS in Rs | 7.02 | 1.36 | 2.09 | 1.47 | 1.16 | 7.75 | 12.16 | 17.81 | 17.92 | 20.70 | 20.69 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 2% |
Growth — CAGR
| Metric | 3Y | 5Y | 10Y |
|---|---|---|---|
| Revenue CAGR | 18.0% | 25.0% | 12.0% |
| Profit CAGR | 19.0% | 81.0% | 13.0% |
Shareholding Pattern
Promoters33.01%
FIIs11.54%
DIIs12.20%
Public43.19%
Promoters33.01%
FIIs11.41%
DIIs12.97%
Public42.56%
Promoters33.01%
FIIs10.54%
DIIs13.99%
Public42.41%
Promoters33.01%
FIIs10.15%
DIIs14.76%
Public42.01%
Promoters33.00%
FIIs9.46%
DIIs16.89%
Public40.55%
Promoters33.08%
FIIs9.89%
DIIs12.34%
Public44.67%
Promoters33.04%
FIIs12.10%
DIIs10.25%
Public44.60%
Promoters33.03%
FIIs11.76%
DIIs11.93%
Public43.28%
Promoters33.01%
FIIs10.15%
DIIs14.76%
Public42.01%
Promoters33.00%
FIIs9.46%
DIIs16.89%
Public40.55%
MEDANTA
Holdings Analysis
Key strengths & risk signals
64
Overall
62
Fundamental
66
Technical
Risks (4)
TOO MUCH PUBLIC HOLDING! 45.55% public ownership - higher volatility risk.
RECOVERY MODE! Current price (1240.0) above 200-day but below 50-day.
NEGATIVE MOMENTUM! Price declined across timeframes - down 5.5% (1 week), 11.7% (1 month), 5.8% (3 months).
WEAK YEAR! Stock declined 6.7% in the last year.
Strengths (4)
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
BULLISH TREND! 50-day average (1417.2) is above 200-day average (1239.6) - positive signal.
OVERSOLD! RSI at 29.3 - potential bounce opportunity.
LOW VOLATILITY! Beta of 0.20 - stable stock, less market risk.
Fundamental & Technical Analysis
64Overall
62Fundamental
66Technical
Fundamental Breakdown
Growth Quality
26/30
Revenue CAGR: 17.2% (VERY GOOD, 13/15). Profit CAGR: 19.5% (VERY GOOD, 13/15).
Profit Margin
5/10
DECENT EFFICIENCY! 11.9% profit margin - acceptable profitability.
PEG Valuation
3/10
OVERVALUED! PEG of 3.08 means expensive relative to growth rate.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0.04% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding
5/20
TOO MUCH PUBLIC HOLDING! 45.55% public ownership - higher volatility risk.
Stability Index
10/10
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
Technical Breakdown
Moving Averages
12/10
BULLISH TREND! 50-day average (1417.2) is above 200-day average (1239.6) - positive signal.
Price Position
2/10
RECOVERY MODE! Current price (1240.0) above 200-day but below 50-day.
Trend Pattern
10/20
BREAKDOWN! Stock has broken below support levels - weakness present.
52W Performance
3/10
WEAK YEAR! Stock declined 6.7% in the last year.
Volume Sentiment
25/30
BULLISH SENTIMENT! In last 30 days: 9 up days, 21 down days. Avg volume on up days: 320,414 vs down days: 220,910. Ratio: 1.45x
RSI
5/5
OVERSOLD! RSI at 29.3 - potential bounce opportunity.
52W Range
3/5
MID RANGE! Trading at 48.3% of 52W range - neutral zone.
Momentum
1/5
NEGATIVE MOMENTUM! Price declined across timeframes - down 5.5% (1 week), 11.7% (1 month), 5.8% (3 months).
Beta
5/5
LOW VOLATILITY! Beta of 0.20 - stable stock, less market risk.
MEDANTA
Concall / Investor Presentation
Earnings call transcripts & AI summaries
| Quarter | Concall | Summary |
|---|---|---|
| Q1FY272026-08-05 | Concall PDF | |
| Q4FY262026-05-20 | Concall PDF | |
| Q3FY262026-02-09 | Concall PDF | |
| Q2FY262025-11-13 | Concall PDF |
Peer Comparison
Healthcare · Medical Care Facilities · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MEDANTA | ₹1,240.00 | 60 | 11.9% | 17.2% | 19.5% | -6.7% | 64 | BREAKDOWN | -0.2% | +10.2% | +26.5% | +12.5% |
| NH | ₹1,719.40 | 42.5 | 9.0% | 20.5% | 9.9% | -3.8% | 59 | APPROACHING SUPPORT | +5.3% | -7.5% | +78.0% | +3.5% |
| KIMS | ₹685.60 | 134.4 | 4.8% | 21.3% | -10.5% | -4.3% | 58 | BREAKDOWN | -47.2% | -2.4% | +35.3% | +9.8% |
| FORTIS | ₹736.50 | 53.1 | 11.0% | 13.3% | 21.0% | -31.2% | 61 | BREAKDOWN | +2.3% | +0.2% | +17.5% | +7.6% |
| ASTERDM | ₹674.40 | 109.3 | 6.5% | 15.7% | -3.0% | -2.8% | 56 | BREAKDOWN | -81.2% | -88.5% | +21.6% | +10.9% |
| MAXHEALTH | ₹846.00 | 56.7 | 16.7% | 22.4% | 9.3% | -28.7% | 55 | BREAKDOWN | +4.9% | -5.6% | +16.7% | +10.4% |
| APOLLOHOSP | ₹7,890.00 | 54.3 | 7.9% | 14.8% | 33.3% | -0.2% | 63 | BREAKDOWN | +34.2% | +9.7% | +20.6% | +6.6% |
| RAINBOW | ₹1,248.90 | 44.4 | 15.7% | 13.1% | 9.7% | -7.6% | 64 | BOUNCE FROM SUPPORT | +13.3% | -21.3% | +33.2% | +2.2% |
Data from TradeAlone · Updated daily
